References & Sources
All references cited in our peptide profiles and educational content.
About Our Sources
Dr Peps aims to base our educational content on peer-reviewed research, clinical guidelines, and reputable medical sources. When formal clinical evidence is limited, we clearly indicate this and describe what is known from preclinical or anecdotal sources.
We prioritize original sources such as:
- •Peer-reviewed journal articles indexed in PubMed
- •Clinical practice guidelines from medical societies
- •FDA and regulatory agency documents
- •Systematic reviews and meta-analyses
References by Peptide
BPC-157
BPC 157: A Review of the Literature on its Use and Safety
Review • 2020
Overview of preclinical studies showing potential tissue-protective effects in animal models.
View source →Gastric Pentadecapeptide BPC 157: A Review of its Mechanisms
Review • 2021
Discusses theoretical mechanisms based on laboratory research; human trials are limited.
View source →
TB-500
Thymosin β4: Structure, Function, and Therapeutic Applications
Review • 2019
Examines preclinical research on thymosin beta-4's role in wound healing and tissue repair.
View source →Potential Therapeutic Uses of Thymosin Beta-4
Other • 2022
Reviews potential applications; notes limited human trial data.
View source →
CJC-1295 with Ipamorelin
Growth Hormone Secretagogues: Clinical Applications
Review • 2021
Reviews mechanisms and potential applications; notes need for more rigorous human trials.
View source →Ipamorelin and CJC-1295: An Overview of Effects
Other • 2022
Discusses anecdotal use and limited clinical data.
View source →
Semaglutide
Semaglutide for Weight Management: STEP Trial Results
PubMed • 2021
Large clinical trial demonstrating significant weight loss in participants without diabetes.
View source →GLP-1 Receptor Agonists: Cardiovascular and Metabolic Effects
Review • 2022
Reviews cardiovascular benefits and safety profile of GLP-1 receptor agonists.
View source →FDA Label: Semaglutide Injection
Guideline • 2023
Official prescribing information including approved indications, dosing, and warnings.
View source →
Tirzepatide
Tirzepatide for Weight Reduction: SURMOUNT Trial Data
PubMed • 2022
Clinical trial showing substantial weight loss in adults with obesity.
View source →Dual GIP/GLP-1 Receptor Agonism: Mechanisms and Clinical Impact
Review • 2023
Discusses how targeting both pathways may enhance metabolic benefits.
View source →FDA Label: Tirzepatide Injection
Guideline • 2023
Official prescribing information with indications, dosing, and safety warnings.
View source →
Melanotan-2
Melanocortin Receptor Agonists: Risks and Unknowns
Review • 2020
Highlights lack of regulatory approval and safety concerns including potential link to skin cancer.
View source →Unregulated Tanning Peptides: Public Health Perspective
Other • 2021
Discusses unmonitored distribution and potential harms of non-approved tanning agents.
View source →
Tesamorelin
Tesamorelin for HIV-associated lipodystrophy
PubMed • 2010
Clinical trial data supporting FDA approval for visceral adipose tissue reduction.
View source →Effects of tesamorelin on body composition
Review • 2013
Review of tesamorelin's effects on abdominal fat and metabolic parameters.
View source →
GHRP-6
GHRP-6 stimulation of growth hormone release
PubMed • 2005
Studies on GHRP-6's mechanism and growth hormone secretion patterns.
View source →Growth hormone secretagogues overview
Review • 2012
Comparative review of various GH-releasing peptides including GHRP-6.
View source →
MOTS-C
MOTS-c: A mitochondrial-encoded regulator of the nucleus
PubMed • 2015
Initial discovery and characterization of MOTS-c peptide.
View source →MOTS-c and metabolic homeostasis
Review • 2020
Review of MOTS-c's role in metabolism and potential therapeutic applications.
View source →
CJC-1295-DAC
Modified GRF(1-29) with extended half-life
PubMed • 2009
Study on DAC technology and extended peptide half-life.
View source →Growth hormone releasing peptides in aging
Review • 2014
Overview of GHRH analogs and their clinical applications.
View source →
PT-141
Bremelanotide for HSDD in premenopausal women
PubMed • 2019
Phase 3 clinical trials supporting FDA approval.
View source →Melanocortin receptor agonists and sexual function
Review • 2020
Mechanism of action and clinical efficacy review.
View source →
IGF-1 LR3
Long R3 IGF-I biological activity
PubMed • 1991
Early characterization of the modified IGF-1 peptide.
View source →IGF-1 and metabolic effects
Review • 2010
Overview of IGF-1's role in growth and metabolism.
View source →
Ipamorelin
Ipamorelin: A selective GH secretagogue
PubMed • 1998
Initial characterization of ipamorelin's selective effects on GH secretion.
View source →Growth hormone secretagogues: Clinical applications
Review • 2011
Comparative review of GH-releasing peptides including ipamorelin.
View source →
Epitalon
Epitalon and pineal gland function
Review • 2003
Russian research on epitalon's effects on circadian regulation.
View source →Peptide bioregulators and aging
Other • 2016
Overview of peptide research in gerontology, primarily from Russian sources.
View source →
AOD-9604
AOD-9604 and adipose tissue metabolism
PubMed • 2001
Early research on the lipolytic effects of the HGH fragment.
View source →Clinical trials of AOD-9604 for obesity
Review • 2005
Overview of clinical trial results for AOD-9604 in weight management.
View source →
KPV
Anti-inflammatory properties of α-MSH peptides
PubMed • 2015
Preclinical research on melanocortin peptides and inflammation.
View source →KPV in inflammatory bowel disease models
Review • 2018
Animal model studies exploring KPV's effects on gut inflammation.
View source →
Thymosin Alpha-1
Thymosin alpha-1 as a clinical immunomodulator
PubMed • 2011
Review of clinical applications and immune modulation mechanisms.
View source →Safety and efficacy of thymosin alpha-1
Review • 2018
Meta-analysis of thymosin alpha-1 use across various conditions.
View source →
LL-37
LL-37: An antimicrobial peptide with pleiotropic functions
PubMed • 2013
Review of LL-37's antimicrobial and immunomodulatory properties.
View source →Cathelicidin in innate immunity
Review • 2017
Overview of cathelicidin's role in immune defense and wound healing.
View source →
Follistatin-344
Follistatin and myostatin regulation
PubMed • 2010
Preclinical research on follistatin's effects on muscle growth.
View source →Myostatin inhibition strategies
Review • 2016
Overview of myostatin inhibition approaches including follistatin.
View source →
GHK-Cu
GHK-Cu in skin remodeling and wound healing
PubMed • 2012
Review of GHK-Cu's effects on collagen synthesis and tissue repair.
View source →Copper peptides in cosmetic applications
Review • 2018
Overview of copper peptide use in skincare and anti-aging.
View source →
5-Amino-1MQ
NNMT inhibition and metabolic effects
PubMed • 2017
Preclinical research on NNMT inhibitors and energy metabolism.
View source →Nicotinamide metabolism and obesity
Review • 2019
Overview of NNMT's role in metabolic regulation.
View source →
HGH Fragment 176-191
HGH fragment and lipid metabolism
PubMed • 2000
Early research on the lipolytic effects of HGH fragments.
View source →Growth hormone fragments for obesity treatment
Review • 2004
Overview of HGH fragment research in weight management.
View source →
GHRP-2
GHRP-2 and growth hormone secretion
PubMed • 1997
Clinical studies on GHRP-2's effects on GH release.
View source →Growth hormone secretagogues comparison
Review • 2008
Comparative analysis of various GH-releasing peptides.
View source →
Hexarelin
Hexarelin: cardiovascular and GH-releasing effects
PubMed • 2005
Research on hexarelin's cardioprotective properties.
View source →Growth hormone secretagogues and receptor desensitization
Review • 2010
Overview of GH secretagogue effects and tolerance development.
View source →
Selank
Selank: anxiolytic and nootropic peptide
Review • 2009
Russian research on Selank's anxiolytic and cognitive effects.
View source →Tuftsin-based peptides in neuromodulation
Other • 2015
Overview of tuftsin-derived peptides, primarily from Russian sources.
View source →
Semax
Semax: neuroprotective and nootropic peptide
Review • 2011
Russian research on Semax's cognitive and neuroprotective effects.
View source →ACTH-derived peptides in brain function
Other • 2014
Overview of ACTH fragment peptides, primarily from Russian sources.
View source →
DSIP
DSIP and sleep regulation
PubMed • 1977
Early research on DSIP isolation and sleep-inducing properties.
View source →Sleep peptides: mechanisms and effects
Review • 2008
Review of sleep-regulating peptides including DSIP.
View source →
Oxytocin
Oxytocin: social behavior and therapeutic potential
PubMed • 2013
Review of oxytocin's role in social cognition and bonding.
View source →Intranasal oxytocin in psychiatric research
Review • 2017
Overview of oxytocin research in autism, anxiety, and social disorders.
View source →
Kisspeptin-10
Kisspeptin and reproductive axis regulation
PubMed • 2010
Research on kisspeptin's role in GnRH secretion and puberty.
View source →Kisspeptin in fertility and reproduction
Review • 2016
Overview of kisspeptin research in reproductive medicine.
View source →
Tesofensine
Tesofensine for obesity treatment
PubMed • 2010
Phase 2 clinical trial data on tesofensine for weight loss.
View source →Triple monoamine reuptake inhibitors in weight management
Review • 2013
Overview of tesofensine's mechanism and efficacy in obesity.
View source →
BPC-157 + TB-500 Combo
BPC-157 tissue repair mechanisms
PubMed • 2020
Preclinical research on BPC-157's effects on healing.
View source →TB-500 and tissue regeneration
PubMed • 2018
Studies on thymosin beta-4 in wound healing and repair.
View source →Peptide combinations in sports medicine
Review • 2021
Overview of peptide stacking approaches in recovery protocols.
View source →
NAD+
NAD+ metabolism and aging
PubMed • 2018
Review of NAD+ decline with age and cellular function.
View source →NAD+ precursors: NMN and NR
PubMed • 2020
Clinical studies on NAD+ precursor supplementation.
View source →NAD+ in cellular energy and DNA repair
Review • 2019
Overview of NAD+'s role in cellular metabolism and longevity.
View source →
Sermorelin
Growth hormone-releasing hormone and growth hormone secretagogue in normal aging
PubMed • 2010
Reviews sermorelin's effects on growth hormone dynamics in aging adults.
View source →Sermorelin: A review of its use in the diagnosis and treatment of growth hormone deficiency
Review • 2015
Comprehensive overview of sermorelin's clinical applications and safety profile.
View source →Effects of GHRH on body composition in adults
PubMed • 2018
Study examining sermorelin's impact on lean body mass and metabolic parameters.
View source →
Thymosin Beta-4
Thymosin β4: A multi-functional regenerative peptide
PubMed • 2017
Comprehensive review of thymosin beta-4's biological functions and therapeutic potential.
View source →Thymosin beta-4 in tissue repair and regeneration
Review • 2020
Examines mechanisms of action in wound healing and tissue regeneration.
View source →Clinical applications of thymosin beta-4 and its derivatives
PubMed • 2021
Discusses both natural thymosin beta-4 and synthetic variants like TB-500.
View source →
Argireline
Efficacy of acetyl hexapeptide-8 in reducing wrinkle depth
Review • 2013
Clinical study examining argireline's effects on facial wrinkles compared to baseline.
View source →Topical peptides in cosmetic dermatology
Review • 2019
Comprehensive review of cosmetic peptides including argireline and their mechanisms.
View source →Safety and efficacy of acetyl hexapeptide-3 in anti-aging formulations
Other • 2020
Evaluates safety profile of argireline in cosmetic products.
View source →
General Educational Resources
- •
FDA MedWatch: The FDA Safety Information and Adverse Event Reporting Program
fda.gov/medwatch - •
PubMed: National Library of Medicine Database
pubmed.ncbi.nlm.nih.gov - •
Safe Needle Disposal: FDA Guidelines
fda.gov/sharps-disposal